Dulaglutide / Trulicity Analog (10mg Research Vial)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
Dulaglutide is a long-acting recombinant human glucagon-like peptide-1 (GLP-1) receptor agonist engineered as a covalent dimer fused to an Fc fragment of modified human IgG4. The Fc fusion prevents renal filtration and endopeptidase DPP-4 degradation, imparting a terminal half-life of approximately 5 days (120 hours). This benchmark pharmacological tool allows precise weekly incretin pathway modulation in rodent and mammalian metabolic disease investigations.
Compound & Molecular Specifications
Certificate of Analysis StandardsFrequently Stacked with Glutathione (Reduced GSH)
Clinically verified combinations activating complementary physiological pathways without receptor competition.
NAD+ (Nicotinamide Adenine Dinucleotide)
NAD+ replenishes the mitochondrial electron transport chain, generating minor reactive oxygen species (ROS) during oxidative phosphorylation. Glutathione acts as the master intracellular ROS scavenger, converting hydrogen peroxide to water and preserving mitochondrial membrane potential.
